Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 12 studies | 46% ± 11% | |
glutamatergic neuron | 11 studies | 77% ± 19% | |
GABAergic neuron | 10 studies | 58% ± 25% | |
astrocyte | 7 studies | 31% ± 17% | |
interneuron | 6 studies | 63% ± 28% | |
retinal ganglion cell | 6 studies | 63% ± 30% | |
fibroblast | 6 studies | 23% ± 7% | |
neuron | 5 studies | 39% ± 12% | |
endothelial cell | 4 studies | 46% ± 21% | |
GABAergic interneuron | 3 studies | 65% ± 3% | |
granule cell | 3 studies | 48% ± 27% | |
GABAergic amacrine cell | 3 studies | 57% ± 13% | |
OFF-bipolar cell | 3 studies | 31% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 45% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 820.17 | 2564 / 2642 | 71% | 4.57 | 498 / 705 |
prostate | 100% | 459.04 | 244 / 245 | 49% | 1.10 | 248 / 502 |
adrenal gland | 100% | 378.50 | 258 / 258 | 19% | 0.68 | 43 / 230 |
bladder | 100% | 1072.67 | 21 / 21 | 11% | 0.57 | 57 / 504 |
uterus | 90% | 395.72 | 153 / 170 | 20% | 1.66 | 93 / 459 |
breast | 89% | 248.05 | 407 / 459 | 16% | 0.36 | 181 / 1118 |
lung | 83% | 138.35 | 480 / 578 | 7% | 0.18 | 76 / 1155 |
ovary | 81% | 173.74 | 145 / 180 | 7% | 0.21 | 32 / 430 |
thymus | 76% | 103.44 | 494 / 653 | 12% | 0.63 | 70 / 605 |
esophagus | 71% | 181.47 | 1030 / 1445 | 11% | 0.23 | 21 / 183 |
intestine | 72% | 239.39 | 699 / 966 | 3% | 0.07 | 17 / 527 |
adipose | 73% | 155.88 | 880 / 1204 | 0% | 0 | 0 / 0 |
skin | 55% | 83.44 | 1002 / 1809 | 16% | 1.26 | 75 / 472 |
stomach | 41% | 102.89 | 146 / 359 | 4% | 0.08 | 11 / 286 |
spleen | 44% | 49.94 | 107 / 241 | 0% | 0 | 0 / 0 |
kidney | 19% | 23.44 | 17 / 89 | 20% | 2.02 | 184 / 901 |
heart | 34% | 41.03 | 289 / 861 | 0% | 0 | 0 / 0 |
pancreas | 5% | 4.58 | 17 / 328 | 23% | 0.51 | 41 / 178 |
blood vessel | 19% | 22.73 | 249 / 1335 | 0% | 0 | 0 / 0 |
liver | 3% | 23.14 | 7 / 226 | 6% | 0.22 | 25 / 406 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.19 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
muscle | 1% | 0.83 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043031 | Biological process | negative regulation of macrophage activation |
GO_0099560 | Biological process | synaptic membrane adhesion |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_1905606 | Biological process | regulation of presynapse assembly |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0009986 | Cellular component | cell surface |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | LRFN5 |
Protein name | Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Leucine rich repeat and fibronectin type III domain containing 5 |
Synonyms | C14orf146 SALM5 |
Description | FUNCTION: Cell adhesion molecule that mediates homophilic cell-cell adhesion in a Ca(2+)-independent manner. Promotes neurite outgrowth in hippocampal neurons. . |
Accessions | ENST00000554120.5 G3V364 Q96NI6 G3V4N1 ENST00000298119.9 ENST00000554171.1 |